✦ LIBER ✦

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma

✍ Scribed by Kimberly M. Brown; Veeriah Siripurapu; Marson Davidson; Steven J. Cohen; Andre Konski; James C. Watson; Tiaynu Li; Vince Ciocca; Harry Cooper; John P. Hoffman

Book ID: 116216169
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 125 KB
Volume: 195
Category: Article
ISSN: 0002-9610
DOI: 10.1016/j.amjsurg.2007.12.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Borderline Resectable Panc

Management of Borderline Resectable Pancreatic Adenocarcinoma With Neoadjuvant GTX Chemotherapy Followed by Combined Chemoradiation

✍ Horowitz, D.P.; Ebiana, V.; Gidea-Addeo, D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Outcome of upfront combination chemother

Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma

✍ Michele Reni; S. Cereda; G. Balzano; P. Passoni; A. Rognone; A. Zerbi; R. Nicole 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 293 KB

Neoadjuvant GTX Chemotherapy and IMRT-ba

Neoadjuvant GTX Chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer

✍ Manish Patel; Sarah Hoffe; Mokenge Malafa; Pamela Hodul; Jason Klapman; Barbara 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

## Abstract ## Background and Objectives To improve the likelihood of achieving a margin‐free resection, neoadjuvant induction chemotherapy with GTX (gemcitabine, docetaxel, and capecitabine) followed by 5‐FU‐IMRT was administered to patients with borderline resectable pancreatic cancer. The utili

P10 Induction chemotherapy followed by c

P10 Induction chemotherapy followed by chemoradiotherapy before surgery for rectal adenocarcinoma

✍ Akbar, A.; Bhatti, A.B.; Syed, A.A.; Khattak, S.; Jamshed, A.; Kazmi, S.S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Preoperative chemoradiation followed by

Preoperative chemoradiation followed by surgical resection for resectable pancreatic cancer: A review of current results

✍ Terence C. Chua; Akshat Saxena 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Is CA19-9 Response Following Chemoradiat

Is CA19-9 Response Following Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer an Early Surrogate for Eventual Survival Outcomes?

✍ Krishnan, S.; Ahmad, M.; Noguera Gonzalez, G.; Das, P.; Minsky, B.; Delclos, M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB